Cargando…

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin

Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with poor prognosis in China. Chemotherapy now is one of the most frequently used treatments for patients with ESCC in middle or late stage, however the effects were often limited by increased chemoresistance or treatment toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Feng, Ding, Xianfei, Wang, Tao, Shan, Zhengzheng, Wang, Jun, Wu, Shaoxuan, Chi, Yanyan, Zhang, Yana, Lv, Zhuan, Wang, Liuxing, Fan, Qingxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390971/ https://www.ncbi.nlm.nih.gov/pubmed/28406985 http://dx.doi.org/10.1371/journal.pone.0174276

Ejemplares similares

miR‐516a‐3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway
por: Chi, Yanyan, et al.
Publicado: (2019)

Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma
por: Chi, Yanyan, et al.
Publicado: (2022)

Chaperone‐mediated autophagy affects tumor cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma
por: Cao, Dujuan, et al.
Publicado: (2021)

LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC
por: Niu, Limin, et al.
Publicado: (2019)

Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin
por: Li, Pin Dong, et al.
Publicado: (2017)

Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo
por: Tang, Jian-Cai, et al.
Publicado: (2017)

Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells
por: Shi, Ling, et al.
Publicado: (2022)

Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions
por: Yu, Hongliang, et al.
Publicado: (2016)

MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT
por: Wang, Feng, et al.
Publicado: (2016)

Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma
por: Wang, Xi, et al.
Publicado: (2016)

Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
por: Zhao, Yong-Qiang, et al.
Publicado: (2021)

MicroRNA‐153‐3p regulates cell proliferation and cisplatin resistance via Nrf‐2 in esophageal squamous cell carcinoma
por: Zuo, Jing, et al.
Publicado: (2020)

MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway
por: Zhao, Yan, et al.
Publicado: (2018)

Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
por: Fu, Qingxia, et al.
Publicado: (2020)

The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo
por: Zhang, Tao, et al.
Publicado: (2013)

miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells
por: Song, Lijie, et al.
Publicado: (2017)

Retracted: Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
por: Cui, Wei, et al.
Publicado: (2020)

Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma
por: Lv, Zhuan, et al.
Publicado: (2017)

Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth
por: Guan, Lulu, et al.
Publicado: (2023)

Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
por: Lu, Zhihao, et al.
Publicado: (2022)

MicroRNA-544 inhibits esophageal squamous cell carcinoma cell proliferation and enhances sensitivity to cisplatin by repressing E2F transcription factor 5
por: Sun, Fengrong, et al.
Publicado: (2019)

Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017)

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023)

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma
por: Song, Kewei, et al.
Publicado: (2023)

Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma
por: Rong, Jun, et al.
Publicado: (2018)

Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway
por: Lu, Yao, et al.
Publicado: (2021)

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
por: DANG, LIFENG, et al.
Publicado: (2014)

Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis
por: He, Wei, et al.
Publicado: (2009)

Overexpression of TAF1L Promotes Cell Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma
por: Zhong, Shan, et al.
Publicado: (2019)

Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
por: Hou, Guiqin, et al.
Publicado: (2014)

Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
por: Yu, Yu, et al.
Publicado: (2015)

Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo
por: Cai, Xianbin, et al.
Publicado: (2015)

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2019)

Metformin Improves the Prognosis of Adult Mice with Sepsis-Associated Encephalopathy Better than That of Aged Mice
por: Song, Gaofei, et al.
Publicado: (2022)

Retracted Article: Panax notoginseng saponins regulate VEGF to suppress esophageal squamous cell carcinoma progression via DVL3-mediated Wnt/β-catenin signaling
por: Chen, Xiaoqi, et al.
Publicado: (2020)

Aberrant Cyclin E and Hepatocyte Growth Factor Expression, Microvascular Density, and Micro-Lymphatic Vessel Density in Esophageal Squamous Cell Carcinoma
por: Xie, Bo, et al.
Publicado: (2019)

Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma
por: Yamada, Moyuru, et al.
Publicado: (2023)

Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies
por: Liang, Huoyan, et al.
Publicado: (2019)

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Shi, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2pdb84k5ab2pha2scupl1josq3